Literature DB >> 24906236

Knockdown of Burton's tyrosine kinase confers potent protection against sepsis-induced acute lung injury.

Panyu Zhou1, Bing Ma, Shuogui Xu, Shijie Zhang, Hongtai Tang, Shihui Zhu, Shichu Xiao, Daofeng Ben, Zhaofan Xia.   

Abstract

Sepsis is a common and critical complication in surgical patients that often leads to multiple organ failure syndrome (MOFS), including acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Despite intensive supportive care and treatment modalities, the mortality of these patients remains high. In this study, we investigated the role of Burton's tyrosine kinase (BTK), a member of the Btk/Tec family of cytoplasmic tyrosine kinases, in the pathogenesis of sepsis, and evaluated the protective effect of in vivo Btk RNA interference in a mouse model of cecal ligation and puncture (CLP)-induced sepsis. After intratracheal injection of Btk siRNA, the mice were then subjected to CLP to induce sepsis. The results demonstrated that this approach conferred potent protection against sepsis-induced ALI, as evidenced by a significant reduction in pathological scores, epithelial cell apoptosis, pulmonary edema, vascular permeability, and the expression of inflammatory cytokines and neutrophil infiltration in the lung tissues of septic mice. In addition, RNA interference of Btk significantly suppressed p-38 and iNOS signaling pathways in transduced alveolar macrophages in vitro. These results identify a novel role for BTK in lethal sepsis and provide a potential new therapeutic approach to sepsis and ALI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24906236     DOI: 10.1007/s12013-014-0050-1

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  14 in total

1.  Effects of Tec Tyrosine Kinase Inhibition on the Inflammatory Response of Severe Acute Pancreatitis-Associated Acute Lung Injury in Mice.

Authors:  Yiteng Meng; Shuo Sha; Jing Yang; Hongbo Ren
Journal:  Dig Dis Sci       Date:  2019-02-14       Impact factor: 3.199

2.  Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.

Authors:  Tiziana Palumbo; Kojiro Nakamura; Charles Lassman; Yoko Kidani; Steven J Bensinger; Ronald Busuttil; Jerzy Kupiec-Weglinski; Ali Zarrinpar
Journal:  Transplantation       Date:  2017-02       Impact factor: 4.939

3.  Optimized Near-IR Fluorescent Agents for in Vivo Imaging of Btk Expression.

Authors:  Eunha Kim; Katherine S Yang; Rainer H Kohler; John M Dubach; Hannes Mikula; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2015-06-09       Impact factor: 4.774

4.  CD38-mediated Inhibition of Bruton's Tyrosine Kinase in Macrophages Prevents Endotoxemic Lung Injury.

Authors:  Joseph Farahany; Yoshikazu Tsukasaki; Amitabha Mukhopadhyay; Manish Mittal; Saroj Nepal; Chinnaswamy Tiruppathi; Asrar B Malik
Journal:  Am J Respir Cell Mol Biol       Date:  2022-02       Impact factor: 6.914

Review 5.  Programmed Cell Death in Sepsis Associated Acute Kidney Injury.

Authors:  Zhifen Wu; Junhui Deng; Hongwen Zhou; Wei Tan; Lirong Lin; Jurong Yang
Journal:  Front Med (Lausanne)       Date:  2022-05-17

6.  Inhibition of BTK protects lungs from trauma-hemorrhagic shock-induced injury in rats.

Authors:  Xinwei Liu; Jingdong Zhang; Wenfeng Han; Yu Wang; Yunen Liu; Yubiao Zhang; Dapeng Zhou; Liangbi Xiang
Journal:  Mol Med Rep       Date:  2017-05-09       Impact factor: 2.952

Review 7.  COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure.

Authors:  Monia Marchetti
Journal:  Ann Hematol       Date:  2020-06-24       Impact factor: 3.673

8.  Ibrutinib for chronic lymphocytic leukemia in the setting of respiratory failure from severe COVID-19 infection: Case report and literature review.

Authors:  Adam Yuh Lin; Michael J Cuttica; Michael G Ison; Leo I Gordon
Journal:  EJHaem       Date:  2020-09-20

9.  X-Linked Immunodeficient Mice With No Functional Bruton's Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure.

Authors:  Caroline E O'Riordan; Gareth S D Purvis; Debora Collotta; Nadine Krieg; Bianka Wissuwa; Madeeha H Sheikh; Gustavo Ferreira Alves; Shireen Mohammad; Lauren A Callender; Sina M Coldewey; Massimo Collino; David R Greaves; Christoph Thiemermann
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

10.  Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia.

Authors:  Alexander P de Porto; Zhe Liu; Regina de Beer; Sandrine Florquin; Onno J de Boer; Rudi W Hendriks; Tom van der Poll; Alex F de Vos
Journal:  Mol Med       Date:  2019-01-15       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.